pyrroles has been researched along with 3-nitropropionic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, K; Han, Z; Hong, NH; Im, WS; Jung, KH; Kang, L; Kim, M; Kim, MW; Lee, ST; Park, JE | 1 |
| Kalonia, H; Kumar, A; Kumar, P | 1 |
| Georgievska, B; Kaindlstorfer, C; Kugler, AR; Mather, RJ; Poewe, W; Sommer, P; Stefanova, N; Wenning, GK | 1 |
3 other study(ies) available for pyrroles and 3-nitropropionic acid
| Article | Year |
|---|---|
Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
Topics: Animals; Atorvastatin; Corpus Striatum; Disease Models, Animal; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Heptanoic Acids; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Mitochondria; Nerve Degeneration; Neurotoxins; Nitric Oxide Synthase Type II; Nitro Compounds; Propionates; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrroles; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley | 2008 |
Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone.
Topics: Animals; Antioxidants; Apoptosis; Behavior, Animal; Body Weight; Caspase 3; Corpus Striatum; Dinoprostone; Huntington Disease; Interleukin-6; Lipid Peroxidation; Lipoxygenase; Male; Mitochondria; Motor Activity; Neuroprotective Agents; NF-kappa B; Nitrites; Nitro Compounds; Propionates; Prostaglandin-Endoperoxide Synthases; Pyrroles; Rats; Rats, Wistar; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2011 |
Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.
Topics: alpha-Synuclein; Animals; Brain; Disease Models, Animal; Enzyme Inhibitors; Humans; Male; Mice, Transgenic; Microglia; Motor Activity; Multiple System Atrophy; Myelin Proteolipid Protein; Neurons; Neuroprotective Agents; Nitro Compounds; Peroxidase; Propionates; Pyrimidinones; Pyrroles; Severity of Illness Index; Treatment Outcome | 2015 |